These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19914260)

  • 21. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats.
    Zorrilla EP; Valdez GR; Weiss F
    Psychopharmacology (Berl); 2001 Dec; 158(4):374-81. PubMed ID: 11797058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment.
    Perrotti LI; Bolaños CA; Choi KH; Russo SJ; Edwards S; Ulery PG; Wallace DL; Self DW; Nestler EJ; Barrot M
    Eur J Neurosci; 2005 May; 21(10):2817-24. PubMed ID: 15926929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating Corticotropin-Releasing Factor Systems in the Nucleus Accumbens, Amygdala, and Bed Nucleus of Stria Terminalis: Incentive Motivation or Aversive Motivation?
    Baumgartner HM; Schulkin J; Berridge KC
    Biol Psychiatry; 2021 Jun; 89(12):1162-1175. PubMed ID: 33726937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRF antagonism within the ventral tegmental area but not the extended amygdala attenuates the anxiogenic effects of cocaine in rats.
    Ettenberg A; Cotten SW; Brito MA; Klein AK; Ohana TA; Margolin B; Wei A; Wenzel JM
    Pharmacol Biochem Behav; 2015 Nov; 138():148-55. PubMed ID: 26441142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure to repeated immobilization stress inhibits cocaine-induced increase in dopamine extracellular levels in the rat ventral tegmental area.
    Sotomayor-Zárate R; Abarca J; Araya KA; Renard GM; Andrés ME; Gysling K
    Pharmacol Res; 2015 Nov; 101():116-23. PubMed ID: 26318765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction.
    Corominas M; Roncero C; Ribases M; Castells X; Casas M
    Neuropsychobiology; 2007; 55(1):2-13. PubMed ID: 17556847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of psychostimulant addiction.
    Chen JC; Chen PC; Chiang YC
    Chang Gung Med J; 2009; 32(2):148-54. PubMed ID: 19403004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Escalated cocaine "binges" in rats: enduring effects of social defeat stress or intra-VTA CRF.
    Leonard MZ; DeBold JF; Miczek KA
    Psychopharmacology (Berl); 2017 Sep; 234(18):2823-2836. PubMed ID: 28725939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that the bed nucleus of the stria terminalis contributes to the modulation of hypophysiotropic corticotropin-releasing factor cell responses to systemic interleukin-1beta.
    Crane JW; Buller KM; Day TA
    J Comp Neurol; 2003 Dec; 467(2):232-42. PubMed ID: 14595770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin releasing factor (CRF) systems: Promoting cocaine pursuit without distress via incentive motivation.
    Baumgartner HM; Granillo M; Schulkin J; Berridge KC
    PLoS One; 2022; 17(5):e0267345. PubMed ID: 35503756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of repeated cocaine on medial prefrontal cortical GABAB receptor modulation of neurotransmission in the mesocorticolimbic dopamine system.
    Jayaram P; Steketee JD
    J Neurochem; 2004 Aug; 90(4):839-47. PubMed ID: 15287889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenalectomy decreases corticotropin-releasing hormone gene expression and increases noradrenaline and dopamine extracellular levels in the rat lateral bed nucleus of the stria terminalis.
    Santibañez M; Gysling K; Forray MI
    J Neurosci Res; 2005 Jul; 81(1):140-52. PubMed ID: 15931675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamatergic neuroplasticity in cocaine addiction.
    Uys JD; Reissner KJ
    Prog Mol Biol Transl Sci; 2011; 98():367-400. PubMed ID: 21199777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extinction-induced neuroplasticity attenuates stress-induced cocaine seeking: a state-dependent learning hypothesis.
    Self DW; Choi KH
    Stress; 2004 Sep; 7(3):145-55. PubMed ID: 15764012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids. Potential for reciprocal interactions between stress and opioid sensitivity.
    Valentino RJ; Van Bockstaele E
    Psychopharmacology (Berl); 2001 Dec; 158(4):331-42. PubMed ID: 11797054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of CRF mRNA in the Rat Extended Amygdala Following Chronic Cocaine: Sex Differences and Effect of Delta Opioid Receptor Agonism.
    Connelly KL; Unterwald EM
    Int J Neuropsychopharmacol; 2020 Feb; 23(2):117-124. PubMed ID: 31867624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute cocaine administration increases NO efflux in the rat prefrontal cortex via a neuronal NOS-dependent mechanism.
    Sammut S; West AR
    Synapse; 2008 Sep; 62(9):710-3. PubMed ID: 18566976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
    Erb S; Kayyali H; Romero K
    Pharmacol Biochem Behav; 2006 Sep; 85(1):206-13. PubMed ID: 16987545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.